Cargando…
Pathophysiology of Pulmonary Fibrosis in the Context of COVID-19 and Implications for Treatment: A Narrative Review
Pulmonary fibrosis (PF) is a feared outcome of many pulmonary diseases which results in a reduction in lung compliance and capacity. The development of PF is relatively rare, but it can occur secondary to viral pneumonia, especially COVID-19 infection. While COVID-19 infection and its complications...
Autores principales: | Tran, Son, Ksajikian, Andre, Overbey, Juliana, Li, Patrick, Li, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406710/ https://www.ncbi.nlm.nih.gov/pubmed/36010566 http://dx.doi.org/10.3390/cells11162489 |
Ejemplares similares
-
Autotaxin in Pathophysiology and Pulmonary Fibrosis
por: Ninou, Ioanna, et al.
Publicado: (2018) -
COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes
por: Mason, Kelly, et al.
Publicado: (2021) -
Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review
por: Duong-Quy, Sy, et al.
Publicado: (2023) -
Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative Review
por: Alsomali, Hana, et al.
Publicado: (2023) -
Combined Pulmonary Fibrosis and Emphysema: Pulmonary Function Testing and a Pathophysiology Perspective
por: Amariei, Diana E., et al.
Publicado: (2019)